Inventor · disambiguated record
Patrick J. Curran
Also filed as: CURRAN PATRICK J
10 granted patents·2 pending applications·49 citations·filing 2003–2011
86Inventor score
Top patents by PatentIndex Score
12 records- 0187US7563798B2Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Granted Jul 21, 2009·11 cites·3 claims
- 0286US7576085B2Imidazopyrazines as cyclin dependent kinase inhibitorsSCHERING CORP·Filed 2005·Granted Aug 18, 2009·10 cites·15 claims
- 0384US7511040B2Imidazopyrazines as protein kinase inhibitorsSCHERING CORP·Filed 2007·Granted Mar 31, 2009·8 cites·17 claims
- 0479US8278337B2Substituted pyridines that are JNK inhibitorsBELANGER DAVID B·Filed 2007·Granted Oct 2, 2012·8 cites·25 claims
- 0577US7115749B2Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agentsSCHERING CORP·Filed 2005·Granted Oct 3, 2006·3 cites·30 claims
- 0675US7196111B2Pyrazolo[1,5a]pyrimidine compounds as antiviral agentsSCHERING CORP·Filed 2003·Granted Mar 27, 2007·8 cites·2 claims
- 0769US7446195B2High affinity thiophene-based and furan-based kinase ligandsSCHERING CORP·Filed 2006·Granted Nov 4, 2008·1 cites·10 claims
- 0848US7511063B2High affinity quinoline-based kinase ligandsSCHERING CORP·Filed 2006·Granted Mar 31, 2009·0 cites·51 claims
- 0945US2007105864A1Methods for inhibiting protein kinasesSCHERING CORP·Filed 2006·Application pending·0 cites
- 1045US2007117804A1Imidazopyrazines as protein kinase inhibitorsSCHERING CORP·Filed 2006·Application pending·0 cites
- 1144US7425640B2Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agentsSCHERING CORP·Filed 2005·Granted Sep 16, 2008·0 cites·24 claims
- 1231US9227971B2Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsSIDDIQUI M ARSHAD·Filed 2011·Granted Jan 5, 2016·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Patrick J. Curran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →